Amyloidosis trials in Hungary

2 of 3 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

  Where

  Budapest VIII

  Age

  18 years to 90 years

  People

  1,200 worldwide

  Run by

  Intellia Therapeutics

  See details and how to joinNCT06128629 · EU 2023-507220-23-00
• Phase 3Taking people
  TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy

  Where

  Balatonfured, Budapest VIII

  Age

  18 years to 85 years

  People

  1,750 worldwide

  Run by

  Alnylam Pharmaceuticals

  See details and how to joinNCT07052903 · EU 2024-519917-72-00